115 related articles for article (PubMed ID: 26303639)
1. Efficacy and safety of intra-arterial steroid infusions in patients with steroid-resistant gastrointestinal acute graft-versus-host disease.
Nishimoto M; Koh H; Hirose A; Nakamae M; Nakane T; Hayashi Y; Okamura H; Yoshimura T; Koh S; Nanno S; Nakashima Y; Takeshita T; Yamamoto A; Sakai Y; Nishida N; Matsuoka T; Miki Y; Hino M; Nakamae H
Exp Hematol; 2015 Dec; 43(12):995-1000. PubMed ID: 26303639
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial methylprednisolone infusion in treatment-resistant graft-versus-host disease.
Weintraub JL; Belanger AR; Sung CC; Stangl PA; Nowakowski FS; Lookstein RL
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):509-12. PubMed ID: 20063098
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial methylprednisolone for severe steroid refractory gastrointestinal graft-versus-host disease.
Bhuller KS; Heran MK; Wu JK; Rassekh SR
Pediatr Blood Cancer; 2014 Dec; 61(12):2321-3. PubMed ID: 25053422
[TBL] [Abstract][Full Text] [Related]
4. Outcome of gastrointestinal graft-versus-host disease according to the treatment response.
Tamaki M; Nakasone H; Misaki Y; Yoshimura K; Gomyo A; Hayakawa J; Kusuda M; Akahoshi Y; Ishihara Y; Kawamura K; Tanihara A; Sato M; Terasako-Saito K; Kameda K; Wada H; Kikuchi M; Kimura SI; Kako S; Kanda Y
Ann Hematol; 2018 Oct; 97(10):1951-1960. PubMed ID: 29860563
[TBL] [Abstract][Full Text] [Related]
5. Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease.
van Groningen LF; Liefferink AM; de Haan AF; Schaap NP; Donnelly JP; Blijlevens NM; van der Velden WJ
Biol Blood Marrow Transplant; 2016 Jan; 22(1):179-82. PubMed ID: 26386320
[TBL] [Abstract][Full Text] [Related]
6. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial catheter directed therapy for severe graft-versus-host disease.
Shapira MY; Bloom AI; Or R; Sasson T; Nagler A; Resnick IB; Aker M; Zilberman I; Slavin S; Verstanding A
Br J Haematol; 2002 Dec; 119(3):760-4. PubMed ID: 12437655
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD.
Bürgler D; Medinger M; Passweg J; Fischmann A; Bucher C
Leuk Res; 2014 Feb; 38(2):184-7. PubMed ID: 24268317
[TBL] [Abstract][Full Text] [Related]
9. Regional intra-arterial steroid treatment in 120 patients with steroid-resistant or -dependent GvHD.
Shapira MY; Klimov A; Vipul S; Grisariu S; Avni BR; Or R; Bloom AI
Bone Marrow Transplant; 2017 Oct; 52(10):1416-1422. PubMed ID: 28650453
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
[TBL] [Abstract][Full Text] [Related]
11. Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract.
Turki AT; Bayraktar E; Basu O; Benkö T; Yi JH; Kehrmann J; Tzalavras A; Liebregts T; Beelen DW; Steckel NK
Ann Hematol; 2019 Oct; 98(10):2407-2419. PubMed ID: 31338570
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
Ganetsky A; Frey NV; Hexner EO; Loren AW; Gill SI; Luger SM; Mangan JK; Martin ME; Babushok DV; Drobyski WR; Smith J; Timlin C; Freyer CW; Stadtmauer EA; Porter DL
Bone Marrow Transplant; 2019 Feb; 54(2):212-217. PubMed ID: 29795429
[TBL] [Abstract][Full Text] [Related]
13. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
14. Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin.
McCaul KG; Nevill TJ; Barnett MJ; Toze CL; Currie CJ; Sutherland HJ; Conneally EA; Shepherd JD; Nantel SH; Hogge DE; Klingemann HG
J Hematother Stem Cell Res; 2000 Jun; 9(3):367-74. PubMed ID: 10894358
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography.
Nakai K; Tajima K; Tanigawa N; Matsumoto N; Zen K; Nomura S; Fujimoto M; Kishimoto Y; Amakawa R; Sawada S; Fukuhara S
Bone Marrow Transplant; 2004 Jun; 33(12):1231-3. PubMed ID: 15094752
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.
Kurtzberg J; Prockop S; Teira P; Bittencourt H; Lewis V; Chan KW; Horn B; Yu L; Talano JA; Nemecek E; Mills CR; Chaudhury S
Biol Blood Marrow Transplant; 2014 Feb; 20(2):229-35. PubMed ID: 24216185
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation.
Wakui M; Okamoto S; Ishida A; Kobayashi H; Watanabe R; Yajima T; Iwao Y; Hisamatsu T; Hibi T; Ikeda Y
Bone Marrow Transplant; 1999 Mar; 23(6):573-8. PubMed ID: 10217188
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.
Holmberg L; Kikuchi K; Gooley TA; Adams KM; Hockenbery DM; Flowers ME; Schoch HG; Bensinger W; McDonald GB
Biol Blood Marrow Transplant; 2006 Feb; 12(2):226-34. PubMed ID: 16443520
[TBL] [Abstract][Full Text] [Related]
19. Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versus-host disease.
Tfayli A; Selby G; Maqbool F; Bierbaum W; Hamadani M
Am J Hematol; 2006 Dec; 81(12):959-62. PubMed ID: 16924649
[TBL] [Abstract][Full Text] [Related]
20. Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease.
Ball LM; Bernardo ME; Roelofs H; van Tol MJ; Contoli B; Zwaginga JJ; Avanzini MA; Conforti A; Bertaina A; Giorgiani G; Jol-van der Zijde CM; Zecca M; Le Blanc K; Frassoni F; Egeler RM; Fibbe WE; Lankester AC; Locatelli F
Br J Haematol; 2013 Nov; 163(4):501-9. PubMed ID: 23992039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
